Spain

 

PMI’s changing business model

Access to primary care is now the number one reason people in the UK want private medical insurance (PMI), according to data collected by UK health insurer Vitality. Other NHS countries have been seeing similar trends since Covid. Katie Tryon, Vitality’s Director of Health Strategy, spoke about how this has completely changed the PMI business model — for the better — at HBI’s conference last month.
July 3, 2024

Veterinary fundamentals as strong as human healthcare, with more consolidation opportunities and less regulatory risk

Speakers at HBI’s first ever panel on the veterinary sector made a compelling case for the sector’s investability to HBI 2024 attendees. Demand is resilient and growing, supported by a growing number of pets as well as greater expenditure from pet owners as the range of services expands. Demand growth is also supported by greater price flexibility than human healthcare typically has in most European countries. And almost all the continent’s markets remain unconsolidated. 
June 26, 2024

HBI News Round Up, 21st June 2024

In this HBI News Round Up, we look at the outcome of Dutch primary care chain Co-Med’s bankruptcy hearing in the Netherlands, French real estate investor Transitions Europe’s entry into Spain’s care home sector, PE firm Columna Capital's latest €290m raise, Spanish hospital group Ribera Salud’s acquisition of Covadonga Hospital in Spain, the extension of the Greek government-backed EquiFund-2 programme to finance life sciences and healthcare start-ups, real estate investor PGIM Real Estate’s acquisition of UK senior housing provider Signature Senior Lifestyle, the first strike by public sector healthcare workers in Sweden in 16 years, and pan-Asian hospital group IHH's desire to enter Vietnam and Indonesia. 
June 21, 2024

HBI News Round Up, 14th June 2024

In this HBI News Round Up, we look at Denmark’s new rules for foreign healthcare workers, healthcare-focused PE fund Tata Capital Healthcare Fund’s multi-million investment into pharma firm Orbicular Pharmaceutical to develop its R&D work, the awarding of a multi-million diabetes treatments contract to American pharma and medical devices group Abbott in Cantabria, Spain, and a partnership in Spain to establish a rare diseases research centre.
June 14, 2024

Healthcare Activos raises new fund worth €650m

Pan-European Spanish healthcare real estate investor Healthcare Activos has launched a new investment fund worth €650 million. This is the REIT’s second fund, and will, in contrast to the first fund, be primarily focused on making investments outside of Spain and Portugal. Jorge Guarner, Activos’ President and Founder, tells us more.
June 7, 2024

Interview: Dr. Volker Wendel, Sanoptis

Dr. Volker Wendel founded Sanoptis in 2018 in Switzerland with Carsten Horn. Six years later, the group has grown to more than 400 locations across six European countries. The group was initially backed by PE firm Telemos Capital, who then sold it to Belgian holding company Group Bruxelles Lambert (in 2022). Wendel explains to us how the group is able to add value to ophthalmologists who join the network and shares which areas the group will be focusing on in the coming years.
May 22, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us